<?xml version="1.0" encoding="UTF-8"?>
<ref id="tbed13734-bib-0063">
 <mixed-citation publication-type="journal" id="tbed13734-cit-0063">
  <string-name>
   <surname>Richardson</surname>, 
   <given-names>P.</given-names>
  </string-name>, 
  <string-name>
   <surname>Griffin</surname>, 
   <given-names>I.</given-names>
  </string-name>, 
  <string-name>
   <surname>Tucker</surname>, 
   <given-names>C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Smith</surname>, 
   <given-names>D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Oechsle</surname>, 
   <given-names>O.</given-names>
  </string-name>, 
  <string-name>
   <surname>Phelan</surname>, 
   <given-names>A.</given-names>
  </string-name>, … 
  <string-name>
   <surname>Stebbing</surname>, 
   <given-names>J.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Baricitinib as potential treatment for 2019‐nCoV acute respiratory disease</article-title>. 
  <source xml:lang="en">Lancet</source>, 
  <volume>395</volume>, 
  <elocation-id>e30</elocation-id>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30304-4</pub-id>
  <pub-id pub-id-type="pmid">32032529</pub-id>
 </mixed-citation>
</ref>
